Nasogastric feeding tube placement in patients with esophageal cancer: application of ultrathin transnasal endoscopy

Cheng Hui Lin, Nai Jen Liu, Ching Song Lee, Jui-Hsiang Tang, Kuo Liang Wei, Chun Yang, Kai Feng Sung, Chi Liang Cheng, Cheng Tang Chiu, Pang Chi Chen

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Background: Patients with esophageal cancer often present with dysphagia and malnutrition. Obstructive symptoms may improve after radiotherapy and chemotherapy. Nutrition support via a nasogastric tube (NG) or gastrostomy is very important during treatment. The newly developed ultrathin endoscope (Olympus, GIF-N230, outer diameter: 6 mm) has a smaller diameter than the standard endoscope and can be introduced into the esophagus via the nasal cavity. This article reports on the use of an ultrathin endoscope for NG placement for patients with esophageal cancer who presented with dysphagia and failed traditional NG tube placement. Methods: A consecutive series of 40 patients with esophageal cancer were referred to our hospital from November 2001 to October 2002 for endoscopic placement of NG tubes due to failure of traditional methods of NG placement. An ultrathin endoscope was used to advance the guidewire into the stomach via the nasal cavity. After withdrawal of the scope, the NG tube was inserted over the guidewire under fluoroscopy. Observations: A total of 71 procedures were performed in 40 patients (37 males, 3 females), age 57 ± 15 years (range, 37-91 y). Seventy procedures (99%) were successful in completing NG tube placement by using an ultrathin transnasal endoscope. Only one procedure failed because the esophageal lumen was completely occluded and the guidewire was not able to be passed through the obstructed site. The average duration that the NG tube was left in place was 49 ± 35 days (range, 2-144 days). No procedure-related complications, such as bleeding or perforation, occurred. Conclusions: Using ultrathin transnasal endoscopy to place an NG tube for esophageal cancer patients is effective and safe. It simplifies the procedures and increases the success rate.

Original languageEnglish
Pages (from-to)104-107
Number of pages4
JournalGastrointestinal Endoscopy
Volume64
Issue number1
DOIs
Publication statusPublished - Jul 1 2006
Externally publishedYes

Fingerprint

Enteral Nutrition
Esophageal Neoplasms
Endoscopy
Endoscopes
Nasal Cavity
Deglutition Disorders
Gastrostomy
Fluoroscopy
Malnutrition
Esophagus
Stomach
Radiotherapy
Hemorrhage
Drug Therapy

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Gastroenterology

Cite this

Nasogastric feeding tube placement in patients with esophageal cancer : application of ultrathin transnasal endoscopy. / Lin, Cheng Hui; Liu, Nai Jen; Lee, Ching Song; Tang, Jui-Hsiang; Wei, Kuo Liang; Yang, Chun; Sung, Kai Feng; Cheng, Chi Liang; Chiu, Cheng Tang; Chen, Pang Chi.

In: Gastrointestinal Endoscopy, Vol. 64, No. 1, 01.07.2006, p. 104-107.

Research output: Contribution to journalArticle

Lin, Cheng Hui ; Liu, Nai Jen ; Lee, Ching Song ; Tang, Jui-Hsiang ; Wei, Kuo Liang ; Yang, Chun ; Sung, Kai Feng ; Cheng, Chi Liang ; Chiu, Cheng Tang ; Chen, Pang Chi. / Nasogastric feeding tube placement in patients with esophageal cancer : application of ultrathin transnasal endoscopy. In: Gastrointestinal Endoscopy. 2006 ; Vol. 64, No. 1. pp. 104-107.
@article{3a3d86e1088e4d94bfb2642985eb540f,
title = "Nasogastric feeding tube placement in patients with esophageal cancer: application of ultrathin transnasal endoscopy",
abstract = "Background: Patients with esophageal cancer often present with dysphagia and malnutrition. Obstructive symptoms may improve after radiotherapy and chemotherapy. Nutrition support via a nasogastric tube (NG) or gastrostomy is very important during treatment. The newly developed ultrathin endoscope (Olympus, GIF-N230, outer diameter: 6 mm) has a smaller diameter than the standard endoscope and can be introduced into the esophagus via the nasal cavity. This article reports on the use of an ultrathin endoscope for NG placement for patients with esophageal cancer who presented with dysphagia and failed traditional NG tube placement. Methods: A consecutive series of 40 patients with esophageal cancer were referred to our hospital from November 2001 to October 2002 for endoscopic placement of NG tubes due to failure of traditional methods of NG placement. An ultrathin endoscope was used to advance the guidewire into the stomach via the nasal cavity. After withdrawal of the scope, the NG tube was inserted over the guidewire under fluoroscopy. Observations: A total of 71 procedures were performed in 40 patients (37 males, 3 females), age 57 ± 15 years (range, 37-91 y). Seventy procedures (99{\%}) were successful in completing NG tube placement by using an ultrathin transnasal endoscope. Only one procedure failed because the esophageal lumen was completely occluded and the guidewire was not able to be passed through the obstructed site. The average duration that the NG tube was left in place was 49 ± 35 days (range, 2-144 days). No procedure-related complications, such as bleeding or perforation, occurred. Conclusions: Using ultrathin transnasal endoscopy to place an NG tube for esophageal cancer patients is effective and safe. It simplifies the procedures and increases the success rate.",
author = "Lin, {Cheng Hui} and Liu, {Nai Jen} and Lee, {Ching Song} and Jui-Hsiang Tang and Wei, {Kuo Liang} and Chun Yang and Sung, {Kai Feng} and Cheng, {Chi Liang} and Chiu, {Cheng Tang} and Chen, {Pang Chi}",
year = "2006",
month = "7",
day = "1",
doi = "10.1016/j.gie.2005.12.036",
language = "English",
volume = "64",
pages = "104--107",
journal = "Gastrointestinal Endoscopy",
issn = "0016-5107",
publisher = "Mosby Inc.",
number = "1",

}

TY - JOUR

T1 - Nasogastric feeding tube placement in patients with esophageal cancer

T2 - application of ultrathin transnasal endoscopy

AU - Lin, Cheng Hui

AU - Liu, Nai Jen

AU - Lee, Ching Song

AU - Tang, Jui-Hsiang

AU - Wei, Kuo Liang

AU - Yang, Chun

AU - Sung, Kai Feng

AU - Cheng, Chi Liang

AU - Chiu, Cheng Tang

AU - Chen, Pang Chi

PY - 2006/7/1

Y1 - 2006/7/1

N2 - Background: Patients with esophageal cancer often present with dysphagia and malnutrition. Obstructive symptoms may improve after radiotherapy and chemotherapy. Nutrition support via a nasogastric tube (NG) or gastrostomy is very important during treatment. The newly developed ultrathin endoscope (Olympus, GIF-N230, outer diameter: 6 mm) has a smaller diameter than the standard endoscope and can be introduced into the esophagus via the nasal cavity. This article reports on the use of an ultrathin endoscope for NG placement for patients with esophageal cancer who presented with dysphagia and failed traditional NG tube placement. Methods: A consecutive series of 40 patients with esophageal cancer were referred to our hospital from November 2001 to October 2002 for endoscopic placement of NG tubes due to failure of traditional methods of NG placement. An ultrathin endoscope was used to advance the guidewire into the stomach via the nasal cavity. After withdrawal of the scope, the NG tube was inserted over the guidewire under fluoroscopy. Observations: A total of 71 procedures were performed in 40 patients (37 males, 3 females), age 57 ± 15 years (range, 37-91 y). Seventy procedures (99%) were successful in completing NG tube placement by using an ultrathin transnasal endoscope. Only one procedure failed because the esophageal lumen was completely occluded and the guidewire was not able to be passed through the obstructed site. The average duration that the NG tube was left in place was 49 ± 35 days (range, 2-144 days). No procedure-related complications, such as bleeding or perforation, occurred. Conclusions: Using ultrathin transnasal endoscopy to place an NG tube for esophageal cancer patients is effective and safe. It simplifies the procedures and increases the success rate.

AB - Background: Patients with esophageal cancer often present with dysphagia and malnutrition. Obstructive symptoms may improve after radiotherapy and chemotherapy. Nutrition support via a nasogastric tube (NG) or gastrostomy is very important during treatment. The newly developed ultrathin endoscope (Olympus, GIF-N230, outer diameter: 6 mm) has a smaller diameter than the standard endoscope and can be introduced into the esophagus via the nasal cavity. This article reports on the use of an ultrathin endoscope for NG placement for patients with esophageal cancer who presented with dysphagia and failed traditional NG tube placement. Methods: A consecutive series of 40 patients with esophageal cancer were referred to our hospital from November 2001 to October 2002 for endoscopic placement of NG tubes due to failure of traditional methods of NG placement. An ultrathin endoscope was used to advance the guidewire into the stomach via the nasal cavity. After withdrawal of the scope, the NG tube was inserted over the guidewire under fluoroscopy. Observations: A total of 71 procedures were performed in 40 patients (37 males, 3 females), age 57 ± 15 years (range, 37-91 y). Seventy procedures (99%) were successful in completing NG tube placement by using an ultrathin transnasal endoscope. Only one procedure failed because the esophageal lumen was completely occluded and the guidewire was not able to be passed through the obstructed site. The average duration that the NG tube was left in place was 49 ± 35 days (range, 2-144 days). No procedure-related complications, such as bleeding or perforation, occurred. Conclusions: Using ultrathin transnasal endoscopy to place an NG tube for esophageal cancer patients is effective and safe. It simplifies the procedures and increases the success rate.

UR - http://www.scopus.com/inward/record.url?scp=33745266406&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745266406&partnerID=8YFLogxK

U2 - 10.1016/j.gie.2005.12.036

DO - 10.1016/j.gie.2005.12.036

M3 - Article

C2 - 16813813

AN - SCOPUS:33745266406

VL - 64

SP - 104

EP - 107

JO - Gastrointestinal Endoscopy

JF - Gastrointestinal Endoscopy

SN - 0016-5107

IS - 1

ER -